The Use of Machine Learning to Reduce Overtreatment of the Axilla in Breast Cancer: Retrospective Cohort Study.
Felix JozsaRose BakerPeter KellyMuneer AhmedMichael DouekPublished in: JMIR perioperative medicine (2022)
We demonstrated that machine learning improves identification of the important subgroup of patients with no palpable axillary disease, positive ultrasound, and more than 2 metastatically involved nodes. A negative ultrasound in patients with no palpable lymphadenopathy is highly indicative of low axillary burden, and it is unclear whether sentinel node biopsy adds value in this situation. Further studies with larger patient numbers focusing on specific breast cancer subgroups are required to refine these techniques in this setting.
Keyphrases
- sentinel lymph node
- machine learning
- ultrasound guided
- lymph node
- fine needle aspiration
- neoadjuvant chemotherapy
- magnetic resonance imaging
- early stage
- artificial intelligence
- big data
- case report
- deep learning
- squamous cell carcinoma
- risk factors
- randomized controlled trial
- radiation therapy
- open label
- breast cancer risk
- locally advanced
- phase iii
- study protocol
- bioinformatics analysis